FDA Oral Wegovy Approval: What the December 22, 2025 Decision Means The FDA's approval of the Wegovy pill represents the first oral GLP-1 medication cleared specifically for weight loss
Does semaglutide interact with [metformin](/metformin) or other diabetes medications
Clothes fit differently even on weeks where the scale plateaus
It will take years to match what semaglutide has established
Common side effects associated with GLP-1 receptor agonists in published clinical literature include nausea, vomiting, diarrhea, constipation, and abdominal discomfort
Consequently, it can lead to improved overall health, wellness, and liver function